Philadelphia College of Osteopathic Medicine

DigitalCommons@PCOM
PCOM Physician Assistant Studies Student
Scholarship

Student Dissertations, Theses and Papers

2020

Is a Modified Dialectical Behavior Therapy (DBT) Regimen
Effective in Reducing PTSD Symptom Severity in Adult Women
with Comorbid PTSD and BPD?
Caroline H. Kearney
Philadelphia College of Osteopathic Medicine

Follow this and additional works at: https://digitalcommons.pcom.edu/pa_systematic_reviews
Part of the Medicine and Health Sciences Commons

Recommended Citation
Kearney, Caroline H., "Is a Modified Dialectical Behavior Therapy (DBT) Regimen Effective in Reducing
PTSD Symptom Severity in Adult Women with Comorbid PTSD and BPD?" (2020). PCOM Physician
Assistant Studies Student Scholarship. 534.
https://digitalcommons.pcom.edu/pa_systematic_reviews/534

This Selective Evidence-Based Medicine Review is brought to you for free and open access by the Student
Dissertations, Theses and Papers at DigitalCommons@PCOM. It has been accepted for inclusion in PCOM
Physician Assistant Studies Student Scholarship by an authorized administrator of DigitalCommons@PCOM. For
more information, please contact library@pcom.edu.

Is a modified dialectical behavior therapy (DBT) regimen effective in reducing PTSD symptom
severity in adult women with comorbid PTSD and BPD?

Caroline H. Kearney, PA-S
A SELECTIVE EVIDENCE BASED MEDICINE REVIEW
In Partial Fulfillment of the Requirements For
The Degree of the Master of Science
In
Health Sciences – Physician Assistant

Department of Physician Assistant Studies
Philadelphia College of Osteopathic Medicine
Philadelphia, Pennsylvania

December 13, 2019

ABSTRACT
OBJECTIVE: The objective of this selective EBM review is to determine whether or not “a
modified dialectical behavior therapy (DBT) regimen is effective in reducing PTSD symptom
severity in adult women with comorbid PTSD and BPD?”
STUDY DESIGN: Review of two randomized controlled trials (RCTs) and one case study
published in English between 2013-2015.
DATA SOURCES: Two RCTs and one case study found via PubMed and Google Scholar
evaluated the benefit of a modified dialectical behavior therapy (DBT) in reducing PTSD
symptom severity in patients with comorbid PTSD and BPD.
OUTCOMES MEASURED: PTSD Symptom severity was measured via the ClinicianAdministered PTSD Scale (CAPS), PTSD Symptom Scale – Interview (PSS-I), and PTSD
Checklist (PCL).
RESULTS: Both RCT’s performed by Bohus et al. (Psychother Psychosom. 2013;82(4):221223.
doi: 10.1159/000348451) and Harned et al. (Behav Res Ther. 2014;55:7-17. doi: 10.1016/j.brat.2
014.01.008) found a statistically significant relationship between a modified DBT regimen,
DBT-PTSD or DBT + DBT PE respectively, and a marked reduction in PTSD symptom severity
as compared to the control group. Granato et al. (J. Clin. Psychol. 2015;71:805 -815. doi: 10.100
2/jclp/22207) conducted a case study that descriptively revealed the patient’s reduced PTSD
symptomatology after completing DBT + DBT PE yet is deficient in its ability to produce
significant data due to their lack of sample size.
CONCLUSIONS: The reported evidence in each study supports the efficacy of a modified DBT
regimen in the marked reduction of PTSD symptom severity in adult women with co-occurring
PTSD and BPD. However, only the two RCTs by Bohus et al and Harned et al. elicited data with
statistical significance. Based on the findings from these two trials, it is evident that women who
severely suffer from both mental illnesses are capable of reducing their PTSD symptomatology
with potential remission from one of the diagnoses after completion of a modified DBT
treatment, as compared to traditional DBT that is unable to elicit the same change. These studies
prove that it is imperative to simultaneously target both symptomatic manifestations of BPD and
PTSD that co-occur and cause significant impairment. Future research should focus on
expanding sample sizes and lengthening follow-up measures to assess the treatment’s long-term
impact on psychological remission.
KEY WORDS: Borderline Personality Disorder, Post-Traumatic Stress Disorder, Dialectical
Behavior Therapy, Psychotherapy.
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INTRODUCTION
Borderline personality disorder (BPD) frequently surfaces from late adolescence to early
adulthood and is characterized by marked impulsivity in areas of spending, substance abuse, or
sexual acts, drastic fluctuations in mood and temper, unstable interpersonal relationships, selfinjurious behavior and distortions of self-image. The pattern of this disorder is impairing, as it is
known to harshly impact close relationships. Those affected by this disorder are unable to
reconcile with other people’s opposing opinions, also referred to as “splitting,” causing the
individual to dramatically go from a state of idealization to devaluation in the smallest conflict. 1
First-line treatment for BPD is psychotherapy, such as dialectical behavior therapy
(DBT), mentalization-based therapy, transference-focused treatment, and cognitive behavioral
therapy.1 DBT is the best empirically supported treatment for BPD and is a comprehensive
treatment program involving individual therapy sessions, group therapy, and therapist teams
prioritizing patients with emotional dysregulation, intentional self-injury, and suicidal
tendencies. Its change-oriented approach originates in the concepts of mindfulness and instilling
awareness about how destructive emotionally driven reactions are in their lives, which then shifts
into a new motivation to create personal change. This realization allows patients to render a new
balance between acceptance and validation of their harmful tendencies. The therapist avoids
portraying concepts as “right” or “wrong,” yet molds their opinion with that of the patient.
Together, they develop strategies to restructure and remove triggers in the patient’s daily
environment, imparting new behavioral techniques that will mitigate negative responses caused
by internal distress and prioritizes preserving negatively affected interpersonal relationships.2
Pharmacotherapy is understudied, yet antipsychotics like olanzapine, antidepressants like
fluoxetine, or mood stabilizers like lamotrigine, may reduce targeted symptoms.1
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Post-traumatic stress disorder (PTSD) arises in individuals after they endure an impactful
traumatic event, which may include sexual/physical assault, childhood trauma, experiencing a
natural disaster or medical catastrophe, or being a prisoner at war. Symptomatic manifestations
are divided into 4 categories: intrusion symptoms or re-experiencing the trauma via flashbacks or
thoughts, avoiding trauma-related stimuli, alterations in cognition and mood, and heightened
levels of arousal. Treatment measures fall in the realm of psychotherapies, as CBT with exposure
therapy are proven efficacious. If patients are unresponsive to the above, SSRIs like sertraline,
SNRIs like venlafaxine, or anti-psychotics like risperidone, are used along with psychotherapy.3
The onset of PTSD not only doubles the frequency of intentional self-injury in
individuals with BPD, but those with both PTSD and BPD are a particularly high-risk group with
a 2-5 times increased risk of completing suicide compared to someone with either BPD or
PTSD.4 While CBT has been successful in the treatment of PTSD alone, CBT explicitly excludes
individuals who self-harm or who are acutely suicidal, essentially eliminating PTSD patients
with comorbid BPD. Traditional CBT therefore fails to treat co-occurring PTSD and BPD. This
comorbidity is gaining clinical significance, as the dual presence maintains and intensifies the
affected individual’s emotional dysregulation, non-suicidal self-injury (NSSI), and dampens
overall remission rates.4 DBT is indicated in BPD patients, but prioritizes self-injury and other
behavior dysfunctions, without specifically targeting a patient’s underlying PTSD diagnosis.5
The lifetime prevalence of PTSD alone is twice as high in women compared to men (1012% vs. 5-6%, respectively). About 30% of people with PTSD have a dual diagnosis of BPD.4,6,7
While there’s limited data on the specific distribution of women with comorbid illnesses, these
statistics suggest a disproportionate effect on females. The cost of a modified DBT protocol has
not yet been standardized in the U.S. The mean total cost of traditional DBT in the U.K. was
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higher than treatment as usual (£5,685 vs. £3,754)6 but after comparing expenditures on health
services pre- and post-treatment, patients saved £36,000 after the post-treatment year.8
Data that account for the yearly visits amongst women with comorbid PTSD and BPD
has not yet been quantified. Additional data separating the number of BPD and PTSD medical
visits is inadequate and falsely low, as providers, especially at the primary care level, often come
up short in their clinical capacity to diagnose these mental disorders.9 Physician assistants (PAs)
are a vital component within primary care, clinically educated in behavioral medicine. Since PAs
and patients form enduring relationships, recognition of new behavioral changes from their
baseline should prompt referral to mental health services even without certainty of a diagnosis.
Currently, there is no universally accepted standardized treatment model for patients with
co-occurring PTSD and BPD. Clinical trials have assessed new forms of DBT that uniquely
target patients with these diagnoses. The two variants of DBT are named DBT-Prolonged
Exposure (DBT + DBT PE) and DBT-PTSD.4,5,10 DBT-PTSD is a comprehensive modular
program that includes a psychoeducation program and trauma-focused interventions that pinpoint
high-risk traits, such as dissociation and self-harm, and imparts new skills via mindfulness
training and exposure-based individual interventions to control their actions associated with
heightened emotional dysregulation.5 DBT + DBT PE starts with 1 year of traditional DBT, and
if/when participants achieve control over their high-priority symptoms, such as suicidal
tendencies or severe quality of life-interfering behaviors, the PE portion begins. Patients are
directly exposed to traumatic memories and learn processing techniques to combat the onset of
global distress.4,10 Standard DBT is not indicated in patients with PTSD, yet because of its cooccurrence with BPD that in turn exacerbates self-harming tendencies, a modified DBT that
specifically targets debilitating behaviors has elicited groundbreaking clinical improvement.
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OBJECTIVE
The objective of this selective EBM review is to determine whether or not “a modified
dialectical behavior therapy (DBT) regimen is effective in reducing PTSD symptom severity in
adult women with comorbid PTSD and BPD?”
METHODS
The search was conducted within PubMed and ClinicalKey using specific inclusion
criteria for this review, in which 2 unblinded RCTs and 1 case study were chosen. The patient
population is composed of adult women, 18 years and older, with PTSD and BPD. The
interventions are modified dialectical behavior therapies (DBT + DBT PE and DBT-PTSD). The
control group used for comparison underwent the treatment-as-usual wait list (TAU-WL)
protocol or traditional DBT. The outcome measured is reduction in PTSD symptom severity.
DATA SOURCES:
Keywords that were used when searching for articles were “BPD,” “PTSD,” “DBT” and
“psychotherapy.” Each article is published in a peer review journal and written in the English
language. Articles were selected based on their relevance to the clinical question and their
inclusion of patient oriented outcomes (POEMS). The inclusion criteria for articles used in this
review were as follows: studies published after 2011, RCT, modified DBT, subjects with
comorbid PTSD and BPD, and adult women 18 years and older. Exclusion criteria for articles
included studies published before 2011, studies with men or children under age 18, standard
DBT, and studies focusing on patients with BPD or PTSD alone. Summary of statistics reported
include p-value, numbers needed to treat (NNT), experimental event rate (EER), control event
rate (CER), relative benefit increase (RBI), and absolute benefit increase (ABI).
OUTCOMES MEASURED
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The outcomes measured in these articles were all POEMs. Harned et al.4 measured the
efficacy of DBT + DBT PE in reducing PTSD symptomology via the PTSD Symptom ScaleInterview (PSS-I), with content corresponding to DSM-IV PTSD diagnostic criteria. PTSD
remission was defined as no longer meeting DSM-IV diagnostic criteria, and PTSD symptomatic
severity reduction was assessed by comparing changes in participant’s scores on the PSS-I
throughout the intervention, with a maximum score of 51 points. Bohus et al.5 measured the
efficacy of DBT-PTSD in reducing PTSD symptom severity via a Clinician-Administered PTSD
Scale (CAPS) score, with “treatment response” defined as a reduction of 30 out of the 60-point
score. Patients who gained “full remission” from their original PTSD diagnosis no longer met the
DSM-IV criteria after completion of the trial. Granato et al.10 measured the efficacy of DBT +
DBT PE in reducing PTSD symptomatology via the 17-item PTSD checklist (PCL) that
corresponds to the DSM-IV PTSD criteria. The participant answered each question on a 5-point
Likert scale: 1 defined as “not at all” to 5 defined as “extremely,” in terms of how significantly
their symptoms impacted them in the past week. The highest possible score totals to 85 points,
with a score < 45 considered to be out of the diagnostic range for PTSD.
Table 1: Demographics & Characteristics of Reviewed Articles
Study

Type

Pts

Age

Inclusion Criteria

Exclusion Criteria

W/D

Interventions

Bohus5
(2013)

RCT

82

1765

Female; ongoing selfharm; diagnosed DSMIV PTSD related to
childhood sexual abuse;
patients met 1 of the
following: current
eating disorder, MDD,
substance abuse, >4
DSM-IV for BPD

Men or children;
lifetime diagnosis of
schizophrenia, current
substance dependence,
BMI < 16.5, intellectual
disability, medical
conditions contradicting
the exposure protocol
(CVD etc.) and suicidal
behavior in the past 4
months.

13

12-week residential
DBT-PTSD multicomponent modular
treatment program.

Harned4
(2014)

RCT

26

1860

Females who meet
DSM-IV criteria for
both BPD and PTSD;
can remember at least
some part of index
trauma; recent/recurrent

Met DSM-IV criteria
for a psychotic disorder,
bipolar disorder, or
mental retardation;
legally mandated to
treatment; if patient

8

1 year of standard DBT
coupled with a modified
DBT + DBT PE protocol
that starts once
improvement in select
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Granato10
(2015)

Case
Study

1

31

self-harm/injury;
participant lives within
close proximity to the
clinic
Adult female who
meets DSM-IV criteria
for both PTSD and
BPD; significant
trauma history

required a primary
treatment for another
life-threatening disorder
None reported

6

high-priority targets
were achieved.

0

10-month period –
begins as standard DBT
requiring 14 sessions and
then integrates DBT +
DBT PE that is delivered
in 27 sessions.

RESULTS
Bohus et al.5 conducted an RCT where 82 adult women were randomized in a 1:1
allocation ratio. Participants in the experimental group completed a DBT-PTSD program versus
the control group where participants completed treatment-as-usual wait list (TAU-WL),
undergoing 6 months of a treatment of their choice excluding DBT-PTSD.5 All patients had a
DSM-IV defined diagnosis of PTSD related to childhood sexual abuse and > 4 DSM-IV defined
diagnosis of BPD. In the first 3 days after randomization, 8 candidates became ineligible to
participate, leaving 74 participants included in the analysis.5 A total of 69 participants completed
the whole trial after 5 participants dropped out during the trial, with no significant dropout rate
associated with either intervention. Participants were further broken down for data analysis into 2
groups based on the severity of their BPD diagnosis according to DSM-IV criteria, with 33
participants who fit into the > 5 BPD criteria (DBT-PTSD, n = 17; TAU-WL, n = 16) versus 41
participants who fit into the < 5 BPD criteria (DBT-PTSD, n = 19; TAU-WL, n = 22).5
Data were collected at admission into the study, at 12 weeks, 18 weeks, and 24 weeks;
post-discharge follow-up at 6 and 12 weeks was garnered from the DBT-PTSD group.5 The
mean change in the CAPS score was greater in the DBT-PTSD group, with a mean reduction of
33.16 points, while those in the TAU-WL group only saw a mean reduction of 2.08 points.5
Both subgroups in the DBT-PTSD arm, meeting > 5 BPD or < 5 BPD, showed significant
weekly improvement on the CAPS scores compared to the control groups (-1.510 + 0.249, p <
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0.001 and -0.496 + 0.234, p = 0.038, respectively).5 More participants on the DBT-PTSD arm
showed a significant response to treatment, with 29.4% (n=5) in DBT-PTSD and 0.0% for TAUWL, with a p-value of 0.039.5 NNT, CER, EER, RBI, and ABI are reported in table 2.
Table 2. Treatment Responders Using CAPS Scores5
CER
EER
RBI
0.0
0.294
0.0

ABI
0.294

NNT
4

Harned et al.4 conducted an RCT in an outpatient setting where 26 participants were
randomized to 2 groups. Participants were allocated in a 2:1 ratio to the experimental group, 1
year of DBT with prolonged exposure (DBT + DBT PE) protocol, versus the control group in
which participants completed 1 year of standard DBT. The experimental group had double the
amount to maximize the amount receiving the intervention under investigation, with n = 17 in the
DBT + DBT PE and n = 9 in DBT alone.4 All participants were adult women who reported
intentional self-injury, had experienced some past traumatic life event, with dual diagnoses of
BPD and PTSD.4 Participants in the control group reported intense urges to commit suicide preand post-treatment as compared to the experimental group, in which 2 people relapsed in
intentional bodily injury and 1 successfully completed suicide during the study.4 In the
experimental group, 1 person made a suicide attempt, and 1 reported self-injury.4
Subjects were assessed pre-treatment, at 4-month intervals within the period of
treatment, and at 3-months follow-up, with a specific focus on the content garnered from
participants after completion of the PSS-I during these time periods.4 There was an attrition of
31%; the dropout rate did not significantly associate to either treatment group. Ten participants
completed the experimental trial after 7 dropped out, and 5 participants completed the control
trial, after 4 dropped out.4
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In the experimental group, 58.3% of participants were in PTSD remission at posttreatment versus 33.3% in the control group.4 Completers in the experimental group were 1.3
times more likely to report clinically significant PTSD symptom reduction and 2 times more
likely to achieve diagnostic remission from PTSD.4 At 3-month follow-up, 50% of the
experimental group remained in PTSD remission, compared to 0% of the control group.4 An
MMANOVA assessing “time x condition x completer” amongst participants who completed the
DBT + DBT PE protocol and with assessing PTSD symptomatology, rendered an F-value =
3.43,42 with a p-value < 0.05.4 This confirmed that the experimental group had the largest PTSD
symptom reduction out of the two treatment groups.4
Table 3: Treatment Responders Using PSS-I Scores4
CER
EER
RBI
0.667
0.833
0.25

ABI
0.166

NNT
6

Granato et al.10 conducted a case study on an adult female with DSM-IV diagnosed
PTSD and BPD, who experienced traumatic childhood events with tendencies to experience
dissociative symptoms that cause her to self-harm.10 The traumatic event of greatest impact
occurred at the age of 12 when she was unknowingly drugged, subsequently gang-raped and
beaten.10 The course of treatment includes a 41-session regimen persisting over a 10-month
period, with standard DBT delivered in the first 14 sessions, wherein the DBT + DBT PE
protocol is introduced and delivered in the remaining 27 sessions.10 Prolonged exposure occurred
in three phases - preexposure, exposure, and termination and consolidation, and was effective in
making the participant confront the memory of past trauma and change fear-based cognitions and
responses to these emotions. PE was discontinued if the patient was actively self-harming.10
The participant completed the 41-session treatment protocol in full.10 Midway through
treatment between sessions 19-20, the patient participated in hallucinogenic drug use and
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intentional self-harm, in which PE was halted for a total of 5 sessions and then resumed. The
patient self-harmed again at session 28 without serious injury, in which PE was halted and
resumed the next session. No other threats to her safety were reported.10 The table below elicits
the participant’s PCL score reduction of 25 points over time, totaling at 55. This score was
determined to be in the diagnostic range for active PTSD according to current guidelines. 10
Table 4. PTSD Checklist (PCL) Scores During PE Treatment10
Session 15 (pre-exposure PE) Session 41 (last PE session)
PCL Score
80
55
Total point reduction
25 points
DISCUSSION
Bohus et al.5 deemed their DBT-PTSD treatment method to have a statistically significant
impact in reducing PTSD symptom severity in the experimental group, also defined as
participants “responding to treatment,” endorsed by a p-value of 0.039. PTSD remission rates
amongst patients meeting diagnostic criteria for BPD was 41.2% vs. 0.0% in the control group,
with p = 0.0058. Harned et al.4 found that both DBT and DBT + DBT PE endeavors were
effective in reducing PTSD symptom severity in participants, as the experimental group achieved
greater reduction in symptoms (80% vs. 60%) and remission rates post-treatment (80% vs. 40%)
as compared to DBT alone, respectively. Individuals with a severe co-occurrence of these
illnesses often self-harm, and traditional PTSD treatment protocols persistently exclude these
persons from receiving care. Yet, those in the experimental group reported a reduced desire to
self-injure, which impacted their perception of the treatment protocol and eventual decline in
PTSD symptoms.4 Both RCTs had an NNT of 4 and 6, translating as a large treatment effect.4,5
Granato et al.10 carried out a case study conducted on one adult female, and researchers
considered their results to be “clinically” significant yet not generalizable to a larger patient
population. The researchers believed that the patient’s dramatic decrease of 25 points on the
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PTSD checklist (PCL) elicits significance in the DBT + DBT PE regimen while also assessing
her clinical picture subsequent, in which her dissociative and self-harming tendencies were
greatly reduced in conjunction with her PTSD symptoms.10
One stark flaw that stands out for all the studies is the lack of a substantial sample size, in
which attrition rates are high in both RCTs. Harned et al.4 had an observed attrition of 31%, and
Bohus et al.5 had an attrition totaling to 16% and neither study carried out worst-case analyses to
account for these losses. There were a multitude of reasons that participants dropped out, as the
impulsive nature of their severe mental illness, lack of global functioning, and self-injurious
behavior most certainly impacted attrition rates. All studies had less than 100 participants, but
the small initial sample size can be explained in part by how individualistic, unique and timeconsuming each treatment plan is, as participants were strategically paired with specially trained
clinicians recruited to function in these studies. Also, the RCTs control groups lack homogeneity
with each other, as Harned et al.4 participants completed standard DBT, yet Bohus et al.5
participants completed a TAU-WL, or their treatment of choice. There is considerable fault in
allowing patients to choose their own treatment in a trial of this nature, as the group may be
confounded by unknown factors that researchers are unable to control.
There were two modified DBT regimens carried out in the three studies, “DBT + DBT
PE” and “DBT-PTSD,” both of which have similar diagnostic and therapeutic aims yet are not
fundamentally identical. Although each target a population of patients with the same diagnoses,
it has been subsequently determined that DBT-PTSD is effective in patients with PTSD and
moderate BPD without life-threatening behavior, as compared to DBT + DBT PE in its efficacy
to target patients with PTSD and severe BPD with self-injurious behavior.11 Knowledge of this
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core disparity amid the two is of importance for researchers when recruiting new subjects and for
future clinicians advocating for standardization and implementation of these treatment measures.
CONCLUSION
It’s of evolving scientific consensus that adult women with the complex diagnoses of
PTSD and BPD suffer through an unrelenting course of illness that has proven to be resistant to
the standard, universally recognized treatments. As previously reviewed, the dual diagnosis of
PTSD and BPD is clearly ubiquitous, as individuals have a higher incidence to intentionally selfinjure and a lower likelihood to benefit from treatment measures that independently target PTSD
or BPD alone. PTSD can actually inhibit someone from achieving full diagnostic remission from
BPD, which illustrates the clinical significance in focusing on reducing PTSD symptoms as a
core feature of these novel DBT treatments to be replicated in future research endeavors. The
modified DBT regimens analyzed in this review, DBT-PTSD and DBT + DBT PE, have proven
a robust statistically significant impact in their ability to bate PTSD symptomatology and allow
subjects to achieve full diagnostic remission from both illnesses, thus rendering them as
promising treatment options in adult women with co-occurring PTSD and BPD.
Future research should prioritize recruitment of a larger, more robust sample with a plan
to combat the high dropout rates. There is great significance in longer-term follow-up measures
especially in an area of this focus, as knowledge of a subject’s lasting psychological remission
and enhanced quality of life thereafter should be of great importance. Further trials should revise
and refine these DBT measures, with an aim to personally standardize and individually tailor a
treatment option to patients with both BPD and PTSD who fall on a spectrum of disease severity.
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